England - London • Industry focus
Goodwin
Praised for its ‘constructive and problem-solving’ approach to issues, the team at Goodwin advises a diverse client roster, which notably includes DJS Antibodie, Novo Holdings and Ducentis BioTherapeutics. Practice co-head David Mardle primarily assists emerging companies with M&A, and co-head Graham Defries advises a number of investors, and biotech and pharmaceutical companies on venture capital exits and investments, in addition to licensing transactions. Co-head Malcolm Bates has broad knowledge surrounding collaborations, outsourcings, and R&D project transactions. Morag Peberdy acts for corporates, having a great deal of expertise in the IP aspects of IPOs and venture capital investments, in addition to IP pipeline arrangements. Kenny Walker-Durrant was promoted to partner in October 2022, and focuses on advising emerging growth companies on corporate matters.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Broad range of skills and areas they can help with.’
‘Approachable and client-friendly, partners stay involved.'
- 'Constructive and problem-solving approach.'
Key clients
- Refeyn Limited
- MiroBio Ltd
- Morgan Stanley & Co., Inc
- William Blair
- Oxford Science Enterprises PLC
- Syncona Portfolio Limited
- DJS Antibodies Limited
- Ducentis BioTherapeutics Ltd
- ReViral Limited
- Biocon Biologics Ltd
- Syndesi Therapeutics
- Vivo Capital LLC
- Boehringer Ingelheim Venture Fund GmbH
- Novo Holdings A/S
- Evotec SE
- Engitix Limited
- SynAffix B.V.
- Stalicla SA
- Grey Wolf Therapeutics Limited
Work highlights
- Advised Morgan Stanley and William Blair, which acted as joint bookrunners for Silence Therapeutics plc’s underwritten ADS offering for gross proceeds of approximately $56.5m.
- Advised Syndesi Therapeutics and its shareholders in relation to the sale of Syndesi’s entire issued share capital to AbbVie.
- Advised Biocon Biologics Ltd on the completed acquisition of substantially all of the global biosimilars business of Viatris Inc. for a total purchase price of $3.3bn.
Lawyers
Hall of Fame
The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.
Practice head
The lawyer(s) leading their teams.
David Mardle, Graham Defries, Malcolm Bates